Unlocking the power of investigative biopsies in glioma
Glioblastoma (GBM) is a primary brain cancer with a devastating prognosis with limited treatment options. Stereotactic biopsies are performed routinely for histological and molecular diagnosis, but could they also be performed for detailed multi-omics investigation into the tumor microenvironment?